INTERNATIONAL PATENT: KADMON CORPORATION, LLC FILES APPLICATION FOR "METHOD OF ADMINISTERING BELUMOSUDIL FOR PATIENT SUBPOPULATIONS WITH HEPATIC IMPAIRMENT"

GENEVA, June 4 -- KADMON CORPORATION, LLC (55 Corporate DriveBridgewater, New Jersey 08807) filed a patent application (PCT/US2023/080712) for "METHOD OF ADMINISTERING BELUMOSUDIL FOR PATIENT SUBPOPULATIONS WITH HEPATIC IMPAIRMENT" on Nov 21, 2023. With publication no. WO/2025/110992, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SAHI, Jasminder (c/o Sanofi, Patent Department450 Water StreetCambridge, MA 02141)

Abstract: The present disclosure provides methods of administering belumosudil and a pharmaceutically accep...